Literature DB >> 26601963

Psychopharmacology of Attention-Deficit Hyperactivity Disorder: Effects and Side Effects.

Javad Golmirzaei, Hamidreza Mahboobi1, Maryam Yazdanparast, Gohar Mushtaq, Mohammad A Kamal, Enayatollah Hamzei.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is a common psychiatric disorder in children which manifests with hyperactivity, impulsivity, and/or inattention. Several drugs are used in treatment of ADHD. Stimulants, atomoxetine, anti-depressants, and bupropion are common medications used in the treatment of ADHD. Stimulants are widely used as the first line treatment in children with ADHD. Their mechanism of action is the release of dopamine and norepinephrine in central nervous system. Methylphenidate is the most common stimulant used for the treatment of ADHD. Methylphenidate significantly reduces ADHD symptoms in children both at home and school and improves their social skills. Methylphenidate is safe in healthy children and has shown to have no cardiac side effects in these patients. Other medications include: Atomoxetine, Amphetamines, Clonidine, Melatonin, and anti-depressants. Effects, side effects, and mechanism of action these drugs have been discussed in this paper.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26601963     DOI: 10.2174/1381612822666151124235816

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

Review 1.  Sleep Problems in Children with Attention Deficit/Hyperactivity Disorder: Current Status of Knowledge and Appropriate Management.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Yu-Shu Huang
Journal:  Curr Psychiatry Rep       Date:  2016-08       Impact factor: 5.285

2.  Editorial: Frontier Views in Designing Therapeutic Candidates for Management of Diverse Diseases.

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 3.  Application of traditional Chinese therapy in sports medicine.

Authors:  Liang Kang; Peijie Liu; Aishi Peng; Bingxin Sun; Yumei He; Zenghao Huang; Minjia Wang; Yushi Hu; Benxiang He
Journal:  Sports Med Health Sci       Date:  2021-02-18

4.  Methylphenidate Use for Emotional Dysregulation in Children and Adolescents with ADHD and ADHD and ASD: A Naturalistic Study.

Authors:  Patrizia Ventura; Concetta de Giambattista; Paolo Trerotoli; Maddalena Cavone; Alessandra Di Gioia; Lucia Margari
Journal:  J Clin Med       Date:  2022-05-22       Impact factor: 4.964

5.  Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development (Part C)).

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

6.  Editorial: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development.

Authors:  Mohammad A Kamal; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

7.  ADHD and Drug Holidays: Effects on Anthropometric Changes during Methylpenidate Treatment.

Authors:  Serkan Turan; Çağatay Ermiş; Victor Pereira-Sanchez; Mustafa Tunctürk; Aynur Akay Pekcanlar
Journal:  Psychopharmacol Bull       Date:  2021-06-01

8.  A Literature Review on the Efficacy and Related Neural Effects of Pharmacological and Psychosocial Treatments in Individuals With Internet Gaming Disorder.

Authors:  Eun Hyun Seo; Hae-Jung Yang; Seung-Gon Kim; Seon-Cheol Park; Sang-Kyu Lee; Hyung-Jun Yoon
Journal:  Psychiatry Investig       Date:  2021-12-08       Impact factor: 2.505

Review 9.  Adenosine Receptors in Neuropsychiatric Disorders: Fine Regulators of Neurotransmission and Potential Therapeutic Targets.

Authors:  Silvia Pasquini; Chiara Contri; Stefania Merighi; Stefania Gessi; Pier Andrea Borea; Katia Varani; Fabrizio Vincenzi
Journal:  Int J Mol Sci       Date:  2022-01-22       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.